Previous studies have demonstrated that all of these pathways are targeted during viral infection, characterized by a high demand for energy (20), a decrease in circulating metabolite levels such as glucose, and an increased profile of glycolytic intermediates (glycerol 3P, pyruvate, etc.)(21) in HIV-infected CD4+ T cells. The gene discussed is CD4; the disease is viral infectious disease.